Search Results 741-750 of 17370 for Break STD Taboo

  1. Breast cancer - Doctors and departments - Mayo Clinic

    ... standard approach. And I think that is one of the unique characteristics of Mayo's approach to research — that patient-centeredness — that really helps to ...

  2. Breast cancer - Doctors and departments - Mayo Clinic

    ... standard approach. And I think that is one of the unique characteristics of Mayo's approach to research — that patient-centeredness — that really helps to ...

  3. Mayo Clinic

    Final days of 5X Challenge! 5X My Gift! The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology. 5X My Gift!

  4. Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

  5. Breast cancer - Doctors and departments - Mayo Clinic

    ... standard approach. And I think that is one of the unique characteristics of Mayo's approach to research — that patient-centeredness — that really helps to ...

  6. Medical Research & Education - Mayo Clinic News Network

    AI Summit highlights patient-centric approach to transform healthcare. The needs of patients are at the forefront of healthcare transformation through ...

  7. A Study of ALX148 With Azacitidine for Higher Risk Myelodysplastic Syndrome - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

  8. News - Scott C. Lester, M.D. - Mayo Clinic

    2026. Mayo Clinic installs first magnetic nanoparticle hyperthermia system for cancer research in the US Feb. 17, 2026, 03:00 p.m. CDT. PST-20473426.

  9. A Study to Evaluate Placental Pathologies Using Ultrasound of the Human Placenta - Mayo Clinic

    Weight greater than 110 pounds (50 kilograms, a standard requirement in obstetrics studies that include blood draws). > 28 weeks gestation. Registration ...

  10. Ibrutinib and Ixazomib Citrate in Treating Participants With Relapsed or Refractory Waldenstrom Macroglobulinemia - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...